RQ Bio Launches with Goal to Transform Treatment and Prevent

- UK-based RQ Biotechnology Ltd (RQ Bio) launches with funding from licensing deal with AstraZeneca for RQ Bio's existing early stage monoclonal antibodies...

Related Keywords

United Kingdom , London , City Of , Mike Westby , Gavin Screaton , Clare Terlouw , Paul Kellam , Astrazeneca , Oxford University Innovation , University Of Oxford , United Rq Biotechnology Ltd Bio , Head Of The Medical Sciences Division , Chief Commercial Officer , Sanofi Executive , Chief Executive Officer , United Kingdom Based , Centauri Therapeutics , Pfizer Rd Executive , Virus Genomics , Imperial College London , Vice President , Infectious Diseases , Kymab United Kingdom , Professor Gavin Screaton , Medical Sciences Division , Lifearc Ventures , Hugo Fry , Rq Bio ,